Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $302 | $225 | $147 | $240 |
| - Cash | $57 | $67 | $75 | $82 |
| + Debt | $57 | $54 | $54 | $54 |
| Enterprise Value | $302 | $212 | $126 | $212 |
| Revenue | $21 | $20 | $19 | $17 |
| % Growth | 8.9% | 1.4% | 15.9% | – |
| Gross Profit | $11 | $11 | $11 | $9 |
| % Margin | 53.3% | 54.9% | 56.8% | 56.3% |
| EBITDA | -$5 | -$9 | -$8 | -$6 |
| % Margin | -21.4% | -47.8% | -43.7% | -37.6% |
| Net Income | -$10 | -$11 | -$10 | -$8 |
| % Margin | -44.8% | -58.5% | -54% | -50.5% |
| EPS Diluted | -0.32 | -0.28 | -0.26 | -0.21 |
| % Growth | -14.3% | -7.7% | -23.8% | – |
| Operating Cash Flow | -$10 | -$6 | -$6 | -$9 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$11 | -$7 | -$7 | -$9 |